ADC/DAC Characterization Scientist II - Antibody Conjugates

BioSpace

Brisbane (CA)

On-site

USD 140,000 - 161,000

Full time

14 days+
Application generator

A complete application in a minute — tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Nurix Therapeutics, Inc. is seeking a scientist to lead analytical workflows for the DAC platform, applying expertise in ADC/DAC characterization to advance candidate compounds from early screening through selection.

The role requires assay design, method development, hands-on execution, and scientific communication to cross-functional teams, with emphasis on LCMS/HPLC methods and quality criteria to drive decisions.

Qualifications

  • BS/BA in biochemistry or analytical chemistry required.
  • MS/MA or PhD with industry experience preferred.
  • Expertise in ADC/DAC & antibody characterization from method development to data interpretation.

Responsibilities

  • Design, execute and own the DAC screening characterization platform including DAR, aggregation, protein quantitation, and QC thresholds.
  • Lead and conduct in-depth characterization of antibodies and advanced DACs including isomers, glycosylation, peptide mapping, and stability.
  • Integrate DAR, purity, hydrophobicity, and stability data into unified assessments with QC cutoffs for go/no-go decisions.
  • Develop, optimize, and troubleshoot LCMS and HPLC methods for throughput and robustness; establish plate-based sample prep workflows.
  • Present findings to project teams and collaborate with chemistry, biology, and bioanalytical groups to align workflows.

Skills

ADC DAC characterization
LCMS analysis
HPLC analysis
Antibody characterization
Data interpretation
Cross-functional communication

Education

BS/BA in biochemistry/analytical chemistry
MS/MA in related field
PhD in related field

Tools

Agilent MassHunter
Byos
Mass spectrometry hardware
HPLC systems

Job description

Nurix Therapeutics, Inc. is seeking a scientist to lead analytical workflows for the DAC platform, applying expertise in ADC/DAC characterization to advance candidate compounds from early screening through selection.

The role requires assay design, method development, hands-on execution, and scientific communication to cross-functional teams, with emphasis on LCMS/HPLC methods and quality criteria to drive decisions.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

DAC & Antibody Conjugate Characterization Scientist II
DAC & Antibody Conjugate Characterization Scientist II

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 140,000 - 161,000
DAC/ADC Characterization Scientist II
DAC/ADC Characterization Scientist II

Nurix Therapeutics • Brisbane (CA)

On-site
USD 140,000 - 161,000
Analytical Scientist, DAC/ADC Characterization
Analytical Scientist, DAC/ADC Characterization

Nurix, Inc. • California (MO)

On-site
USD 140,000 - 161,000
DAC/ADC Characterization Scientist II
DAC/ADC Characterization Scientist II

NURIX • South San Francisco (CA)

On-site
USD 133,000 - 148,000
Bioanalytical Scientist I, DACs — LC-MS/MS Expert
Bioanalytical Scientist I, DACs — LC-MS/MS Expert

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 124,000 - 143,000
Bioanalytical Scientist, DACs & LC-MS/MS PK/PD
Bioanalytical Scientist, DACs & LC-MS/MS PK/PD

Nurix Therapeutics • Brisbane (CA)

On-site
USD 90,000 - 130,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Nurix Therapeutics • Brisbane (CA)

On-site
USD 140,000 - 161,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

BioSpace • Brisbane (CA)

On-site
USD 140,000 - 161,000
Senior Scientist, DAC Bioanalysis & LC-MS/MS
Senior Scientist, DAC Bioanalysis & LC-MS/MS

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 130,000 - 180,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 140,000 - 161,000